Hossam Abdulkhalek: Understanding Outcomes for Cancer Patients Receiving Systemic Therapy ePoster at ESMO 2025
Hossam Abdulkhalek, Divisional Clinical Director of Cancer and Clinical Services at Western Health and Social Care Trust, shared a post on LinkedIn:
“I’m delighted to share that our abstract ‘Assessment of Performance, Characteristics of Deaths within 30 Days of Systemic Anti-Cancer Therapy in Cancer Patients (APCD-SACT for Better) : North West Cancer Centre Experience’ has been accepted as an ePoster at ESMO 2025 in Berlin!
It focuses on improving safety and understanding outcomes for cancer patients receiving systemic therapy — based on our work at North West Cancer Centre.
Proud to contribute to ongoing efforts that put patient care and continuous learning at the centre of oncology.
Grateful to my team and colleagues who supported this project—and looking forward to engaging with global oncology professionals at ESMO 2025.”
More posts featuring ESMO 2025 on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023